A class-action lawsuit against Zantac has begun in the United States as a result of the supplement being linked to breast cancer, even though the company denied this link. Thousands of Zantac suits are expected to be filed over the coming years linking Zantac to breast cancer. The suit names Zantac, its ingredients, and its distributors as well as its chief executive officer, Mark Zantac. The suit is also accusing Mark Zantac of fraud because he maintained in statements and leadership positions at both his direct and indirect times in the company that the Zantac product was "unlike any other dietary supplement." He went on to say that no other dietary supplement had such positive results. Explore more wisdom about Zantac Lawsuit, view here.
Zantac Lawsuit says it could help the plaintiffs win the case against Zantac. Zantac manufacturers, through statements made in court filings, maintained that Zantac is not a carcinogen, that it has no effect on the long-term health of people who use it, and that the claims of the plaintiffs are unreasonable and unjustified. The Zantac lawsuit maintains that although Zantac did not produce any medical records to support these statements, it did develop clinical studies that suggested that Zantac can cause various forms of cancer including breast cancer in some cases. The studies suggested that Zantac may have been responsible for five cancer deaths. It is also seeking damages for negligence, damages for missold products, and medical malpractice.
As stated in its legal papers, Zantac intends to defend itself vigorously. Mark Zantac said in a deposition that the studies conducted by his company's scientists showed no connection between Zantac and breast cancer diagnosis. However, when pressed by plaintiffs' lawyers, Zantac admitted that a certain woman in its consumer panel died of cancer treatment using Zantac. Zantac lawyers admit that the woman had missed several doctor appointments as a result of Zantac and said her death might have been a result of "unnatural causes." To remark the understanding about Zantac Lawsuit, read more here.
Plaintiffs contend that the above statements are evidence that Zantac manufactures a product that could be dangerous. They further argue that Zantac failed to warn consumers that its peptic ulcer medication was defective because, according to the complaint, Zantac failed to disclose that ulcer was one of the drugs it sold as a treatment for gastric reflux. Furthermore, Zantac failed to warn consumers that stomach ulcers are caused by peptic ulcer and that peptic ulcers can lead to esophageal cancer. Further, Zantac failed to inform consumers that peptic ulcers can lead to "strict anaphylactic shock," which is potentially fatal. The complaint also contends that Zantac failed to warn consumers that its stomach in peptic ulcer tablet is not an effective treatment for gastric reflux.
Zantac Lawsuit further claims that generic versions of Zantac did not contain the warning it required under law. In order to qualify for approval of a generic drug, generic drugs must meet identical guidelines as patented drugs do. Zantac failed to warn consumers that its generic drugs posed serious side effects just like patented drugs. Moreover, Zantac failed to warn that its generic drugs were prone to substitutions and that they would fail to provide the same therapeutic results as Zantac's patented drugs. Finally, the lawsuit contends that Zantac did not warn consumers that its peptic ulcer tablet was not an effective treatment for gastric reflux. Seek more info at https://www.huffpost.com/entry/zantac-recall-cancer_l_5d936a14e4b0019647af3757.
Plaintiffs are asking for damages for wrongful deaths, injuries, lost wages, medical expenses, mental anguish, punitive damages, and future earning losses. As previously reported by the Associated Press, Zantac Lawsuit is seeking damages for the accidental drowning of their child who was playing with Zantac Lawsuit's son on a Zantac boat. This accident occurred on March 24th, when the boat was in direct collision with the back of a moving semi-trailer truck. The boy was attempting to save his infant brother who was tossed overboard. Zantac has settled lawsuits against the driver of the semi-trailer truck, the manufacturer of the tractor trailer used in the accident, the trucking company, and the driver of the boat.
